Workflow
Global Strategy
icon
Search documents
Ocugen: A Retinal Disease Juggernaut In The Making
Seeking Alpha· 2025-09-23 15:11
Group 1 - The author, Sean Daly, specializes in ETFs, biotech, and FINTECH solutions within the banking sector [1] - He has a strong academic background, having taught international finance and financial risk management at Pace University and served as a visiting lecturer at Princeton University [1] - Daly's research interests include diverse topics such as Chinese urbanization, multilateral currency swap arrangements, energy geopolitics, and Asia's sovereign wealth funds [1] Group 2 - The author has a beneficial long position in the shares of OCGN, indicating a personal investment interest [2] - The article reflects the author's own opinions and is not influenced by compensation from any company mentioned [2]
SPX Technologies: The Benefits, Costs, And Risks Of Its Global Strategy
Seeking Alpha· 2025-08-21 01:41
Group 1 - SPX Technologies, Inc. generates nearly 20% of its revenues outside the U.S. [1] - The company operates as a global entity with production, distribution, and service in over 16 countries [1]
X @Bloomberg
Bloomberg· 2025-08-06 15:16
Swiss firms rethink global strategy after tariff surge https://t.co/cfpHxk3k2k ...